India Pharma Inc battled strong headwinds last year and witnessed a slowdown in the pace of its growth. Even as it strives to regain its growth momentum, the Indian pharma industry continues to face disruptions from evolving regulatory landscapes and growing market complexities.
But, market analysts predict that India has a huge growth potential. As per IBEF's report released in Janurary 2019, the country’s pharma industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach $55 billion and become one of the top three pharma markets by 2020. Therefore, if the industry aligns its development strategies to embrace the challenges in this transitory environment and turn them into competitive advantages, the scales could be tilted in its favour and Brand India Pharma can re-emerge stronger than ever before.
Express Pharma, the leading industry publication from The Indian Express Group, is organising a conference for the stakeholders of the pharma industry in Vizag. Under the theme, ‘Shaping the future of Brand India Pharma’, experts and veterans of the industry will address critical issues such as:
RK Beach Road Opposite,
Visakhapatnam, Andhra Pradesh 530002